KEISER DAVID W 4
4 · ALEXION PHARMACEUTICALS INC · Filed May 8, 2009
Insider Transaction Report
Form 4
KEISER DAVID W
Director
Transactions
- Sale
Common Stock, par value $.0001 per share
2009-05-07$35.00/sh−2,200$77,000→ 167,346 total
Footnotes (1)
- [F1]The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1 (c))(1) of the Securities Exchange Act.